114 related articles for article (PubMed ID: 2371174)
1. Prostatic tumor (R3327) skeletal metastasis.
Geldof AA; Rao BR
Prostate; 1990; 16(4):279-90. PubMed ID: 2371174
[TBL] [Abstract][Full Text] [Related]
2. Factors in prostate cancer metastasis.
Geldof AA; Rao BR
Anticancer Res; 1990; 10(5A):1303-6. PubMed ID: 2241106
[TBL] [Abstract][Full Text] [Related]
3. Progression delay of prostate tumor skeletal metastasis effects by bisphosphonates.
Sun YC; Geldof AA; Newling DW; Rao BR
J Urol; 1992 Oct; 148(4):1270-3. PubMed ID: 1404658
[TBL] [Abstract][Full Text] [Related]
4. Radionuclide therapy for prostate cancer lumbar metastasis prolongs symptom-free survival in a rat model.
Geldof AA; van den Tillaar PL; Newling DW; Teule GJ
Urology; 1997 May; 49(5):795-801. PubMed ID: 9145995
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of the vertebral vein in prostate cancer metastasis.
Nishijima Y; Uchida K; Koiso K; Nemoto R
Adv Exp Med Biol; 1992; 324():93-100. PubMed ID: 1492629
[TBL] [Abstract][Full Text] [Related]
6. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo.
Achbarou A; Kaiser S; Tremblay G; Ste-Marie LG; Brodt P; Goltzman D; Rabbani SA
Cancer Res; 1994 May; 54(9):2372-7. PubMed ID: 8162583
[TBL] [Abstract][Full Text] [Related]
7. Prostate secretory protein of 94 amino acids (PSP-94) and its peptide (PCK3145) as potential therapeutic modalities for prostate cancer.
Shukeir N; Garde S; Wu JJ; Panchal C; Rabbani SA
Anticancer Drugs; 2005 Nov; 16(10):1045-51. PubMed ID: 16222145
[TBL] [Abstract][Full Text] [Related]
8. Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer.
Shukeir N; Arakelian A; Kadhim S; Garde S; Rabbani SA
Cancer Res; 2003 May; 63(9):2072-8. PubMed ID: 12727822
[TBL] [Abstract][Full Text] [Related]
9. Role of the vertebral venous system in metastatic spread of cancer cells to the bone.
Harada M; Shimizu A; Nakamura Y; Nemoto R
Adv Exp Med Biol; 1992; 324():83-92. PubMed ID: 1492628
[TBL] [Abstract][Full Text] [Related]
10. A synthetic 15-mer peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercalcemia.
Shukeir N; Arakelian A; Chen G; Garde S; Ruiz M; Panchal C; Rabbani SA
Cancer Res; 2004 Aug; 64(15):5370-7. PubMed ID: 15289344
[TBL] [Abstract][Full Text] [Related]
11. Development of skeletal metastasis by human prostate cancer in athymic nude mice.
Shevrin DH; Kukreja SC; Ghosh L; Lad TE
Clin Exp Metastasis; 1988; 6(5):401-9. PubMed ID: 3378377
[TBL] [Abstract][Full Text] [Related]
12. Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo.
Rabbani SA; Gladu J; Harakidas P; Jamison B; Goltzman D
Int J Cancer; 1999 Jan; 80(2):257-64. PubMed ID: 9935208
[TBL] [Abstract][Full Text] [Related]
13. Autoradiographic studies of rhenium-188-hydroxyethylidine diphosphonate in normal skeleton and osteoblastic bone metastases in a rat model of metastatic prostate cancer.
Liepe K; Geidel HH; Bergmann R; Haase M; Runge R; Kotzerke J
Nucl Med Commun; 2009 Sep; 30(9):693-9. PubMed ID: 19528873
[TBL] [Abstract][Full Text] [Related]
14. New model for the induction of osteoblastic bone metastases in rat.
Liepe K; Geidel H; Haase M; Hakenberg OW; Runge R; Kotzerke J
Anticancer Res; 2005; 25(2A):1067-73. PubMed ID: 15868947
[TBL] [Abstract][Full Text] [Related]
15. An experimental model simulating local recurrence and pelvic lymph node metastasis following orthotopic induction of prostate cancer.
Vieweg J; Heston WD; Gilboa E; Fair WR
Prostate; 1994 Jun; 24(6):291-8. PubMed ID: 8208623
[TBL] [Abstract][Full Text] [Related]
16. Models for cancer skeletal metastasis: a reappraisal of Batson's plexus.
Geldof AA
Anticancer Res; 1997; 17(3A):1535-9. PubMed ID: 9179192
[TBL] [Abstract][Full Text] [Related]
17. Renal tubular reabsorption of phosphate is positively related to the extent of bone metastatic load in patients with prostate cancer.
Buchs N; Bonjour JP; Rizzoli R
J Clin Endocrinol Metab; 1998 May; 83(5):1535-41. PubMed ID: 9589651
[TBL] [Abstract][Full Text] [Related]
18. A rat model of metastatic spinal cord compression using human prostate adenocarcinoma: histopathological and functional analysis.
Sarabia-Estrada R; Zadnik PL; Molina CA; Jimenez-Estrada I; Groves ML; Gokaslan ZL; Bydon A; Witham TF; Wolinsky JP; Sciubba DM
Spine J; 2013 Nov; 13(11):1597-606. PubMed ID: 23810458
[TBL] [Abstract][Full Text] [Related]
19. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.
Wu TT; Sikes RA; Cui Q; Thalmann GN; Kao C; Murphy CF; Yang H; Zhau HE; Balian G; Chung LW
Int J Cancer; 1998 Sep; 77(6):887-94. PubMed ID: 9714059
[TBL] [Abstract][Full Text] [Related]
20. Serum osteocalcin in monitoring bone metastases in advanced prostatic cancer.
Marcellini M; De Carli P; Abbolito MR; Mainiero G; Cantiani R
Eur Urol; 1992; 21 Suppl 1():102-4. PubMed ID: 1385126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
